29 Jul 2022 , 02:43 PM
Net profit of Sun Pharmaceuticals Industries rose 42.70% to Rs 2060.88 crore in the quarter ended June 2022 as against Rs 1444.17 crore during the previous quarter ended June 2021. Sales rose 10.08% to Rs 10643.97 crore in the quarter ended June 2022 as against Rs 9669.43 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 10643.97 | 9669.43 | 10 |
| OPM % | 27.10 | 29.18 | – |
| PBDT | 2872.84 | 2938.51 | -2 |
| PBT | 2284.84 | 2435.29 | -6 |
| NP | 2060.88 | 1444.17 | 43 |
Powered by Capital Market – Live News
Related Tags

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.